Laboratory Evaluation for Hemolytic Anemia
Order a complete blood count with reticulocyte count, lactate dehydrogenase (LDH), haptoglobin, indirect (unconjugated) bilirubin, and direct antiglobulin test (DAT) as your initial laboratory workup for suspected hemolytic anemia 1, 2.
Core Laboratory Tests
The diagnosis of hemolytic anemia requires demonstrating both anemia and evidence of accelerated red blood cell destruction:
Essential Initial Tests
Complete Blood Count (CBC): Establishes the presence and severity of anemia; hemoglobin is preferred over hematocrit for accuracy 3. The CBC also evaluates other cell lines—abnormalities in two or more cell lines warrant hematology consultation 3.
Reticulocyte Count: This is the single most important test to confirm appropriate bone marrow response to hemolysis. An elevated reticulocyte count (reticulocytosis) indicates active hemolysis with adequate marrow compensation 4, 1, 2. Use the absolute reticulocyte count or reticulocyte index adjusted for degree of anemia 3.
Lactate Dehydrogenase (LDH): Elevated LDH is a sensitive marker of red cell destruction, released from lysed erythrocytes 4, 1, 2.
Haptoglobin: Decreased or undetectable haptoglobin is highly specific for intravascular hemolysis, as haptoglobin binds free hemoglobin released from destroyed red cells 4, 1, 2.
Indirect (Unconjugated) Bilirubin: Elevated indirect bilirubin results from increased heme catabolism during hemolysis 4, 1, 2.
Critical Differentiating Test
- Direct Antiglobulin Test (DAT/Coombs Test): This test is the cornerstone for classifying hemolytic anemia 1, 5. A positive DAT indicates immune-mediated hemolysis (autoimmune hemolytic anemia, drug-induced, transfusion reactions), while a negative DAT points toward non-immune causes (hemoglobinopathies like sickle cell disease, membrane defects, enzyme deficiencies, microangiopathic hemolytic anemia) 1, 2.
Secondary Diagnostic Tests
Once hemolysis is confirmed, proceed based on DAT results:
Peripheral Blood Smear
Always obtain a peripheral smear to identify red cell morphology abnormalities 1, 2. Specific findings guide diagnosis:
- Spherocytes suggest hereditary spherocytosis or immune hemolysis
- Schistocytes indicate microangiopathic hemolytic anemia
- Sickle cells point to sickle cell disease
- Target cells suggest hemoglobinopathies
Additional Testing Based on Clinical Context
Iron studies (ferritin, transferrin saturation): Important to exclude iron deficiency contributing to anemia, particularly if mean corpuscular volume (MCV) is low 3
Hemoglobin electrophoresis: For suspected hemoglobinopathies when DAT is negative 6
G6PD screening: For suspected enzyme deficiency, particularly with oxidative stress history 6
Specialized enzyme assays: Only if routine tests are inconclusive and hereditary enzymopathy is suspected 7, 6
Common Pitfalls
Do not rely on hematocrit alone—it is less reproducible and affected by storage conditions and patient variables like serum glucose 3. Do not skip the peripheral smear—morphology often provides the specific diagnosis 2. Do not assume all hemolysis is immune-mediated—the DAT distinguishes immune from non-immune causes, fundamentally changing management 1.
In acute presentations with severe anemia, jaundice, or hemodynamic instability, obtain all core tests simultaneously rather than sequentially to expedite diagnosis and treatment 4, 1.